查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2023-2028 年全球臨床研究服務市場預測
市場調查報告書
商品編碼
1410063

2023-2028 年全球臨床研究服務市場預測

Global Clinical Research Services Market - Forecasts from 2023 to 2028
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

臨床研究服務市場預計將從2021年的591.03億美元成長到2028年的880.29億美元，複合年成長率為5.86%。

慢性病發病率的增加、對循證醫療保健的需求不斷增加以及藥物和設備核准的監管要求正在推動臨床研究服務市場的成長。由於國際上對這些服務的強勁需求，臨床研究服務市場正在顯著擴大。 CRO（委外研發機構）、大學研究機構和提供臨床研究服務的專業公司正在爭奪臨床研究服務市場的佔有率。隨著臨床試驗複雜性的增加和全球合作的擴大，臨床研究服務市場規模預計將進一步擴大，從而促進醫學的改進和新藥的開發。

介紹

不斷成長的臨床研究服務市場是醫療保健產業中一個快速成長的領域，包括旨在協助臨床試驗的創建和進行的各種服務。臨床研究服務對於推進醫學知識、評估新藥的安全性和有效性以及確保監管合規性至關重要。

臨床研究服務包括試驗設計、病患招募、資料管理、現場監測、統計分析和監管備案。 CRO（委外研發機構）、大學研究機構和其他專業組織提供這些服務。隨著臨床試驗複雜性、全球合作和技術改進的增加，臨床研究服務的市場規模預計將顯著成長。這項擴張預計將有助於發現新藥、提高病人安全和改善整個醫學。

臨床研究服務市場的主要企業

  • IQVIA： IQVIA 是臨床研究服務的世界領導者，提供廣泛的服務，包括試驗設計、設施管理、病患招募和資料管理。
  • 美國實驗室控股公司（LabCorp）： LabCorp 被稱為臨床研究服務供應商，包括臨床試驗、生物標記測試、中心實驗室服務和臨床試驗管理解決方案。
  • PAREXEL INTERNATIONAL CORPORATION： PAREXEL INTERNATIONAL CORPORATION：提供全面的臨床研究服務，包括臨床試驗管理、資料管理、監管建議和病患招募。
  • ICON plc： ICON 提供從頭到尾的臨床研究服務，包括臨床試驗設計、地點選擇、病患招募、資料管理和監管支援。

對循證醫療保健的需求不斷成長

對循證醫療保健的需求不斷成長，表明人們越來越注重使用科學證據和嚴格的研究來為醫療決策提供資訊並改善患者的治療結果。這種方法旨在確保醫療干預、治療和衛生政策基於有效性、安全性和成本效益的可靠證據。實證醫療保健的目標是透過將最佳現有證據與臨床經驗和患者選擇相結合，彌合研究與實踐之間的差距。這種需求的動機是提高護理品質、減少實踐差異以及有效分配醫療保健資源。

臨床研究活動外包

臨床研究業務外包是指將臨床試驗和研究的特定部分委託給CRO（合約藥物委外研發機構）等外部服務供應商。這使得製藥和生物技術公司能夠利用專業組織的知識和資源，減輕內部團隊的負擔並提高業務效率。外包的好處包括擴充性、降低成本以及更快招募研究參與者。外包使公司能夠專注於其核心競爭力，同時確保合規性和按時完成臨床試驗。總體而言，外包有助於加快藥物開發過程並加強醫學研究。

生物製藥和生技產業的擴張

生物製藥和生技產業的擴張是指這些領域的顯著成長和發展。這種擴張是由研發投資增加、技術突破和創新藥物發現等因素所推動的。慢性病發病率的增加、個體化醫療方法以及對新治療方法的需求都在推動市場成長。因此，對支持新藥、生技藥品和醫療設備的發現和測試的臨床研究服務的需求不斷增加，臨床研究服務市場預計將成長。

臨床研究服務市場在預測期內將持續成長

臨床研究服務市場按服務類型、治療領域、最終用戶和地區進行細分。服務類型進一步分為臨床資料管理服務、品管服務、臨床監測服務等。最終用戶進一步分為製藥和生物技術公司、受託研究機構以及學術和研究機構。

北美引領臨床研究服務市場

北美在臨床研究服務市場佔有率中佔據主導地位。該地區的優勢因素包括完善的醫療基礎設施、蓬勃發展的製藥和生物技術產業以及有利的法規環境。此外，大型委外研發機構（CRO）和大學研究機構遍布整個北美。美國尤其發揮關鍵作用，因為其在臨床研究方面的巨大投資和大量正在進行的臨床試驗。儘管歐洲和亞太地區等其他地區也是臨床研究服務市場的重要參與企業，但北美佔據了壓倒性的佔有率。

主要進展

2023年6月，IQVIA RIM智慧標籤發布。它是生命科學領域的綜合標籤解決方案，提供主導驅動策略，以實現更有效率、更合規的全球標籤管理。生命科學公司可以利用這種獨特的技術來簡化規劃、追蹤和實施監管標籤的系統和流程。 2023 年 5 月，領先的基因藥物製造商 Forge Biologics 宣布與全球生命科學公司 LabCorp 建立基因療法藥物研究和製造合作夥伴關係。

目錄

第1章簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表

第2章調查方法

  • 調查資料
  • 資訊來源
  • 研究設計

第3章執行摘要

  • 研究亮點

第4章市場動態

  • 市場促進因素
  • 市場抑制因素
  • 波特五力分析
    • 供應商的議價能力
    • 買方議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 業內競爭對手之間的對抗關係
  • 產業價值鏈分析

第5章全球臨床研究服務市場：依服務類型

  • 介紹
  • 臨床試驗管理服務
  • 臨床資料管理服務
  • 監管服務
  • 臨床監測服務
  • 品管服務
  • 生物分析服務
  • 其他

第6章全球臨床研究服務市場：依治療領域

  • 介紹
  • 腫瘤學
  • 心血管疾病
  • 感染疾病
  • 神經病學
  • 呼吸系統疾病
  • 其他

第7章全球臨床研究服務市場：依最終使用者分類

  • 介紹
  • 製藥和生物技術公司
  • 委託研究組織（CROS）
  • 學術研究機構
  • 其他
  • 全球臨床研究服務市場：按地區
  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 其他
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 印尼
    • 台灣
    • 其他

第8章競爭環境及分析

  • 主要企業及策略分析
  • 新興企業和市場盈利
  • 合併、收購、協議和合作
  • 供應商競爭力矩陣

第9章 公司簡介

  • IQVIA HOLDINGS INC.
  • PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC（PPD）
  • PAREXEL INTERNATIONAL CORPORATION
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
  • COVANCE INC.（A SUBSIDIARY OF LABORATORY CORPORATION OF AMERICA HOLDINGS）
  • SYNEOS HEALTH INC.
  • MEDPACE HOLDINGS, INC.
  • WUXI APPTEC INC.
  • ICON PLC
  • SGS SA
簡介目錄
Product Code: KSI061615739

The global clinical research services market is expected to grow at a CAGR of 5.86% from US$59.103 billion in 2021 to US$88.029 billion in 2028.

The rising frequency of chronic illnesses, increased demand for evidence-based healthcare, and regulatory requirements for medication and device approvals are propelling global clinical research services market growth. Given the strong demand for these services internationally, the global clinical research services market size is expanding significantly. Contract Research Organisations (CROs), university research organizations, and specialized companies providing clinical research services compete for the global clinical research services market share. As clinical trial complexity rises and worldwide collaboration expands, the global clinical research services market size is predicted to expand further, allowing improvements in medical science and the development of novel medicines.

Introduction:

The global clinical research services market growth is a booming area of the healthcare industry that includes a diverse variety of services targeted at assisting in the creation and execution of clinical trials. Clinical research services are critical in furthering medical knowledge, assessing the safety and efficacy of novel medicines, and assuring regulatory compliance.

Clinical research services include study design, patient recruiting, data management, site monitoring, statistical analysis, and regulatory filings, among other things. Contract research organizations (CROs), university research organizations, and other specialized entities provide these services. The global clinical research services market size is expected to develop significantly as clinical trial complexity, worldwide collaboration, and technology improvements increase. This expansion is projected to aid in the discovery of novel medicines, improve patient safety, and contribute to the improvement of medical science as a whole.

Key Players in the Global Clinical Research Services Market:

  • IQVIA: IQVIA is a global leader in clinical research services, providing a wide variety of services such as study design, site administration, patient recruiting, and data management.
  • Laboratory Corporation of America Holdings (LabCorp): LabCorp is a well-known clinical research services provider, including clinical trial testing, biomarker testing, central laboratory services, and clinical trial management solutions.
  • PAREXEL International Corporation: PAREXEL offers a comprehensive variety of clinical research services, including clinical trial management, data management, regulatory advice, and patient recruiting.
  • ICON plc: ICON provides clinical research services from start to finish, including clinical trial design, site selection, patient recruiting, data administration, and regulatory assistance.

Drives:

Growing Demand for Evidence-Based Healthcare:

The increased demand for evidence-based healthcare indicates a rising emphasis on using scientific evidence and rigorous research to inform medical decision-making and enhance patient outcomes. This method seeks to guarantee that medical interventions, therapies, and healthcare policies are based on trustworthy evidence of efficacy, safety, and cost-effectiveness. The goal of evidence-based healthcare is to close the gap between research and practice by combining the best available evidence with clinical experience and patient choices. This need is motivated by a desire for better treatment quality, less variability in practice, and a more efficient allocation of healthcare resources.

Outsourcing of Clinical Research Activities:

Clinical research operations are outsourced when specific components of clinical trials and research are delegated to external service providers such as Contract Research Organisations (CROs). This practice enables pharmaceutical and biotechnology firms to tap into the knowledge and resources of specialized organizations, lowering the pressure on in-house teams and enhancing operational efficiency. Outsourcing provides advantages such as enhanced scalability, cost savings, and speedier recruitment of research participants. It enables businesses to focus on their core capabilities while assuring regulatory compliance and clinical trial completion on schedule. Overall, outsourcing helps to speed the drug development process and enhance medical research.

Expansion of Biopharmaceutical and Biotechnology Industries:

The biopharmaceutical and biotechnology industries' expansion refers to the tremendous growth and development seen in these areas. This expansion is being driven by causes such as increasing investment in R&D, technological breakthroughs, and the discovery of innovative medicines. The rising frequency of chronic illnesses, personalized medical methods, and the need for novel therapies all help to drive market growth. As a consequence, there is a greater need for clinical research services to assist in the discovery and testing of novel pharmaceuticals, biologics, and medical devices, resulting in the potential for growth in the clinical research services market.

The Global Clinical Research Services Market is growing at a constant pace in the forecast period.

The market for global clinical research services is segmented by service type, therapeutic area, end-user, and geography. Service type is further segmented into clinical data management services, quality management services, clinical monitoring services, etc. End-users are further segmented into pharmaceutical and biotechnological companies, contract research organizations, and academic and research institutions.

North America is the Market Leader in the Global Clinical Research Services Market.

North America dominates the global clinical research services market share. Factors contributing to the region's supremacy include a well-established healthcare infrastructure, a thriving pharmaceutical and biotechnology industry, and a favorable regulatory environment. Furthermore, big contract research organizations (CROs) and university research organizations are well-represented throughout North America. Because of its enormous investment in clinical research and the vast number of ongoing clinical trials, the United States, in particular, plays a critical role. While other areas, such as Europe and the Asia Pacific, are important participants in the Global Clinical Research Services Market, North America has the dominant global clinical research services market share.

Key Developments:

  • In June 2023, IQVIA RIM Smart Labelling, a comprehensive labeling solution for the life sciences sector that delivers an intelligence-driven strategy for more efficient and compliant worldwide label management, was launched. Life sciences firms may use this one-of-a-kind technology to streamline regulatory label planning, tracking, and execution systems and processes.
  • In May 2023, Forge Biologics, a major maker of genetic medicines, announced a cooperation with LabCorp, a renowned global life sciences firm, to research and manufacture gene therapies.

Segmentation

By Service Type

  • Clinical Trial Management Services
  • Clinical Data Management Services
  • Regulatory Services
  • Clinical Monitoring Services
  • Quality Management Services
  • Bioanalytical Services
  • Others

By Therapeutic Area

  • Oncology
  • Cardiovascular Diseases
  • Infectious Diseases
  • Neurology
  • Respiratory Diseases
  • Others

By End-User

  • Pharmaceutical And Biotechnology Companies
  • Contract Research Organizations (Cros)
  • Academic And Research Institutions
  • Others

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Taiwan
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Sources
  • 2.3. Research Design

3. EXECUTIVE SUMMARY

  • 3.1. Research Highlights

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. GLOBAL CLINICAL RESEARCH SERVICES MARKET, BY SERVICE TYPE

  • 5.1. Introduction
  • 5.2. CLINICAL TRIAL MANAGEMENT SERVICES
  • 5.3. CLINICAL DATA MANAGEMENT SERVICES
  • 5.4. REGULATORY SERVICES
  • 5.5. CLINICAL MONITORING SERVICES
  • 5.6. QUALITY MANAGEMENT SERVICES
  • 5.7. BIOANALYTICAL SERVICES
  • 5.8. OTHERS

6. GLOBAL CLINICAL RESEARCH SERVICES MARKET, BY THERAPEUTIC AREA

  • 6.1. Introduction
  • 6.2. ONCOLOGY
  • 6.3. CARDIOVASCULAR DISEASES
  • 6.4. INFECTIOUS DISEASES
  • 6.5. NEUROLOGY
  • 6.6. RESPIRATORY DISEASES
  • 6.7. OTHERS

7. GLOBAL CLINICAL RESEARCH SERVICES MARKET, BY END-USER

  • 7.1. Introduction
  • 7.2. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
  • 7.3. CONTRACT RESEARCH ORGANIZATIONS (CROS)
  • 7.4. ACADEMIC AND RESEARCH INSTITUTIONS
  • 7.5. OTHERS
  • 7.6. GLOBAL CLINICAL RESEARCH SERVICES MARKET, BY GEOGRAPHY
  • 7.7. Introduction
  • 7.8. North America
    • 7.8.1. United States
    • 7.8.2. Canada
    • 7.8.3. Mexico
  • 7.9. South America
    • 7.9.1. Brazil
    • 7.9.2. Argentina
    • 7.9.3. Others
  • 7.10. Europe
    • 7.10.1. United Kingdom
    • 7.10.2. Germany
    • 7.10.3. France
    • 7.10.4. Italy
    • 7.10.5. Spain
    • 7.10.6. Others
  • 7.11. Middle East and Africa
    • 7.11.1. Saudi Arabia
    • 7.11.2. UAE
    • 7.11.3. Others
  • 7.12. Asia Pacific
    • 7.12.1. Japan
    • 7.12.2. China
    • 7.12.3. India
    • 7.12.4. South Korea
    • 7.12.5. Indonesia
    • 7.12.6. Taiwan
    • 7.12.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Emerging Players and Market Lucrativeness
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Vendor Competitiveness Matrix

9. COMPANY PROFILES

  • 9.1. IQVIA HOLDINGS INC.
  • 9.2. PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC (PPD)
  • 9.3. PAREXEL INTERNATIONAL CORPORATION
  • 9.4. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
  • 9.5. COVANCE INC. (A SUBSIDIARY OF LABORATORY CORPORATION OF AMERICA HOLDINGS)
  • 9.6. SYNEOS HEALTH INC.
  • 9.7. MEDPACE HOLDINGS, INC.
  • 9.8. WUXI APPTEC INC.
  • 9.9. ICON PLC
  • 9.10. SGS SA